A Prospective Study, Single-arm, Multicentre, Observational to Evaluate Safety and Effectiveness of Stent Ultimaster Tansei Coronary Stent in Complex Coronary Lesions.

CompletedOBSERVATIONAL
Enrollment

501

Participants

Timeline

Start Date

August 21, 2020

Primary Completion Date

May 1, 2023

Study Completion Date

February 1, 2024

Conditions
Ischemic Heart DiseaseCoronary Artery Disease
Interventions
DEVICE

TANSEI stent

stenting with the TANSEI sirolimus-eluting stent

Trial Locations (17)

13005

Hospital General Universitario de Ciudad Real, Ciudad Real

14004

Hospital Universitario Reina Sofia, Córdoba

15006

Hospital Universitario de A Coruña, A Coruña

15706

Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela

21005

Hospital General Juan Ramon Jimenez, Huelva

24001

Hospital Universitario de León, León

27003

Hospital Universitario Lucus Agusti, Lugo

28222

Hospital Universitario Puerta de Hierro, Majadahonda

29010

Hospital Universitario Virgen de La Victoria, Málaga

30120

Hospital Clinico Universitario Virgen Arrixaca, Murcia

33394

Hospital Universitario de Cabueñes, Gijón

35010

Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria

39008

Hospital Universitario Marques de Valdcilla, Santander

46010

Hospital Clinico Universitario de Valencia, Valencia

02006

Hospital General Universitario, Albacete

08003

Hospital Del Mar, Barcelona

08035

Hospital Universitari Vall D'Hebron, Barcelona

All Listed Sponsors
lead

Fundación EPIC

OTHER

NCT04475536 - A Prospective Study, Single-arm, Multicentre, Observational to Evaluate Safety and Effectiveness of Stent Ultimaster Tansei Coronary Stent in Complex Coronary Lesions. | Biotech Hunter | Biotech Hunter